SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001561743-14-000033
Filing Date
2014-05-14
Accepted
2014-05-14 14:34:03
Documents
12
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kindred10qq-1.htm 10-Q 443354
2 EXHIBIT 10.1 exhibit101restictedstockag.htm EX-10.1 32163
3 EXHIBIT 31.1 exhibit311.htm EX-31.1 12651
4 EXHIBIT 31.2 exhibit312.htm EX-31.2 12668
5 EXHIBIT 32.1 exhibit321.htm EX-32.1 5029
6 EXHIBIT 32.2 exhibit322.htm EX-32.2 5532
  Complete submission text file 0001561743-14-000033.txt   2965235

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT kin-20140331.xml EX-101.INS 423156
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kin-20140331.xsd EX-101.SCH 19863
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kin-20140331_cal.xml EX-101.CAL 31259
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kin-20140331_def.xml EX-101.DEF 97670
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kin-20140331_lab.xml EX-101.LAB 274157
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kin-20140331_pre.xml EX-101.PRE 147601
Mailing Address 58 WEST PORTAL AVE., #105 SAN FRANCISCO CA 94127
Business Address 58 WEST PORTAL AVE., #105 SAN FRANCISCO CA 94127 415-596-1557
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36225 | Film No.: 14840821
SIC: 2834 Pharmaceutical Preparations